Studies have also demonstrated that high concentrations of proinflammatory molecules, including tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), contribute to the accelerated development of atherosclerosis and cardiovascular events in patients with RA and SLE (35). This evidence concerns the gene IL6 and systemic lupus erythematosus.